Wall Street analysts expect CubeSmart (CUBE) to post quarterly earnings of $0.66 per share in its upcoming report, which indicates a year-over-year decline of 2.9%. Revenues are expected to be $280.47 million, up 21.2% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its earnings, it is vital to take into ...

Group 1 - Analysts expect C3.ai, Inc. (AI) to report a quarterly loss of -$0.29 per share, reflecting a year-over-year decline of 141.7% [1] - Revenue is projected to be $75.82 million, down 23.2% from the same quarter last year [1] - There has been no revision in the consensus EPS estimate over the past 30 days, indicating a stable outlook among analysts [1] Group 2 - The estimated revenue from Professional services is $7.48 million, indicating a year-over-year decline of 42.9% [4] - Analysts project Subscription revenue to be $68.32 million, reflecting a decrease of 20.3% from the previous year [4] - The estimated Gross margin for Professional services is 74.1%, down from 80.0% year-over-year [4] Group 3 - The average prediction for Gross margin in Subscription is 49.9%, compared to 56.0% in the same quarter last year [5] - C3.ai shares have decreased by 17.5% in the past month, contrasting with the Zacks S&P 500 composite's decline of 0.8% [5] - C3.ai holds a Zacks Rank of 4 (Sell), indicating expected underperformance relative to the overall market [5]

Wall Street analysts expect UFP Industries (UFPI) to post quarterly earnings of $1.03 per share in its upcoming report, which indicates a year-over-year decline of 14.2%. Revenues are expected to be $1.4 billion, down 4% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its earnings, it is vital to take int ...

Core Insights - Medtronic (MDT) is expected to report quarterly earnings of $1.33 per share, a decline of 4.3% year-over-year, with revenues projected at $8.9 billion, reflecting a 7.3% increase compared to the previous year [1] Revenue Estimates - Analysts estimate 'Net Sales- World Wide Revenue- Cardiovascular' to be $3.37 billion, indicating a year-over-year increase of 10.8% [4] - 'Net Sales- World Wide Revenue- Neuroscience' is projected to reach $2.59 billion, reflecting a 5.3% increase year-over-year [4] - 'Net Sales- World Wide Revenue- Neuroscience- Cranial & Spinal Technologies' is expected to be $1.32 billion, a 6% increase from the prior year [5] - 'Net Sales- World Wide Revenue- Neuroscience- Neuromodulation' is forecasted at $505.68 million, indicating a 6.2% year-over-year change [5] U.S. Revenue Estimates - 'Net Sales- U.S. Revenue' is anticipated to be $4.53 billion, suggesting a 6.9% increase year-over-year [6] - 'Net Sales- U.S. Revenue- Neuroscience- Neuromodulation' is projected at $342.56 million, reflecting a 4.8% increase [6] International Revenue Estimates - 'Net Sales- ROW- Neuroscience- Cranial & Spinal Technologies' is expected to reach $338.62 million, indicating a 10.3% year-over-year change [6] - 'Net Sales- ROW- Neuroscience- Specialty Therapies' is projected at $335.35 million, reflecting a 7.1% increase [7] - 'Net Sales- ROW- Cardiovascular- Cardiac Rhythm & Heart Failure' is expected to be $826.64 million, indicating a 7.4% increase [8] - 'Net Sales- ROW- Diabetes' is projected at $522.47 million, reflecting a significant 14.3% increase from the previous year [8] - The consensus estimate for 'Net Sales- ROW- Cardiovascular' stands at $1.77 billion, indicating an 8.5% year-over-year change [8] Stock Performance - Medtronic shares have shown a return of +5.2% over the past month, outperforming the Zacks S&P 500 composite, which has seen a -0.3% change [9]

Core Insights - MKS (MKSI) is expected to report quarterly earnings of $2.51 per share, reflecting a 16.7% increase year-over-year, with revenues projected at $1.03 billion, a 10.2% increase compared to the previous year [1] Revenue Estimates - Analysts project 'Net Revenues- Semiconductor' to reach $421.37 million, indicating a 5.3% increase from the prior-year quarter [4] - 'Net Revenues- Specialty Industrial' is expected to be $285.23 million, showing a 1.5% increase year-over-year [4] - 'Net Revenues- Electronics and Packaging' is estimated at $298.92 million, reflecting a 17.7% year-over-year change [4] - 'Net Revenues- Products' is forecasted to be $866.43 million, indicating a 5.2% increase from the previous year [5] - 'Net Revenues- MSD (Materials Solutions Division)' is expected to reach $327.51 million, showing a 9.2% increase year-over-year [5] - 'Net Revenues- PSD (Photonics Solutions Division)' is projected at $266.08 million, reflecting a 1.6% increase from the prior year [6] - 'Net Revenues- Services' is forecasted to be $126.87 million, indicating a 14.3% year-over-year change [6] - 'Net Revenues- VSD (Vacuum Solutions Division)' is estimated at $399.70 million, reflecting a 7.5% increase year-over-year [6] Stock Performance - MKS shares have increased by 30.7% in the past month, contrasting with the Zacks S&P 500 composite's decline of 0.3%, indicating strong market performance [6] - MKS holds a Zacks Rank 1 (Strong Buy), suggesting it is expected to outperform the overall market in the near term [6]

Core Insights - Telus is expected to report quarterly earnings of $0.18 per share, unchanged from the same period last year, with revenues projected at $3.93 billion, reflecting a year-over-year increase of 2.2% [1] - There have been no revisions in the consensus EPS estimate over the last 30 days, indicating stability in analysts' forecasts [1][2] Financial Metrics - Total telecom subscriber connections are projected to reach 21.02 million, up from 20.18 million in the same quarter last year [4] - Subscribers for connected devices are expected to be 4.30 million, compared to 3.73 million a year ago [4] - Internet subscribers are estimated at 2.81 million, slightly up from 2.76 million in the previous year [5] - TV subscribers are forecasted to reach 1.45 million, an increase from 1.39 million year-over-year [5] - Security subscribers are estimated at 1.16 million, up from 1.12 million in the same quarter last year [6] - Residential voice subscribers are projected to be 977.06 thousand, down from 1.03 million a year ago [6] - Mobile phone subscribers are expected to be 10.33 million, compared to 10.15 million in the same quarter last year [7] Market Performance - Telus shares have returned +5.6% over the past month, outperforming the Zacks S&P 500 composite, which showed no change [7] - The company holds a Zacks Rank 2 (Buy), indicating expectations of beating overall market performance in the near future [7]

Group 1 - Industria de Diseno Textil SA (IDEXY) shares increased by 5.5% to $17, following a trading session with higher-than-average volume, contrasting with a 3.3% loss over the past four weeks [1] - The company is expected to report quarterly earnings of $0.29 per share, reflecting a year-over-year increase of 141.7%, with revenues projected at $13.72 billion, up 14.7% from the previous year [2] - The consensus EPS estimate for IDEXY has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [3] Group 2 - Industria de Diseno Textil is part of the Zacks Retail - Apparel and Shoes industry, where Designer Brands (DBI) also operates, having seen a 10.2% increase to $7.44 in the last trading session, despite a -11.8% return over the past month [3] - Designer Brands has a consensus EPS estimate of -$0.48 for the upcoming report, which is a 9.1% decrease from the previous year, and currently holds a Zacks Rank of 1 (Strong Buy) [4]

Core Insights - Corebridge Financial (CRBG) is expected to report quarterly earnings of $1.11 per share, reflecting a year-over-year decline of 9.8% [1] - Revenue is anticipated to be $5.06 billion, which represents a slight increase of 0.9% from the previous year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 0.2%, indicating a reassessment by analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3] Key Metrics Forecast - The consensus estimate for 'Premiums' is $1.30 billion, indicating a year-over-year increase of 13.9% [5] - 'Total Corebridge- Advisory fee and other income' is expected to be $107.71 million, reflecting a significant decline of 48.7% year-over-year [5] - 'Policy fees' are forecasted to reach $620.41 million, down 15.9% from the previous year [5] Revenue Projections - 'Total Corebridge- Net investment income' is projected at $3.06 billion, showing a year-over-year increase of 6.3% [6] - 'Revenue- Life Insurance' is expected to be $1.08 billion, a slight increase of 0.5% from the prior year [6] - 'Revenue- Individual Retirement' is forecasted at $1.68 billion, indicating a decline of 7.5% year-over-year [6] Assets Under Management - 'Assets Under Management and Administration (AUMA) - Individual Retirement' is estimated to be $122.13 billion, down from $160.13 billion year-over-year [7] - 'Assets Under Management and Administration (AUMA) - Group Retirement' is projected at $130.28 billion, an increase from $124.30 billion year-over-year [8] - 'Assets Under Management and Administration (AUMA) - Total' is expected to reach $383.80 billion, down from $404.00 billion year-over-year [9] Stock Performance - Corebridge shares have decreased by 3% over the past month, contrasting with the Zacks S&P 500 composite's increase of 0.9% [10] - The company holds a Zacks Rank of 5 (Strong Sell), indicating expectations of underperformance relative to the overall market [10]

Core Viewpoint - Shell (SHEL) is expected to report quarterly earnings of $1.21 per share, a 0.8% increase year-over-year, with revenues projected at $68.09 billion, reflecting a 1.9% year-over-year increase [1]. Earnings Projections - The consensus EPS estimate has been revised 0.3% lower over the last 30 days, indicating a reevaluation by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Estimates - Analysts predict the 'INTEGRATED GAS - Realised gas price' to be $6.90 per thousand scf, down from $8.10 in the same quarter last year [5]. - 'INTEGRATED GAS - LNG liquefaction volumes' are forecasted to reach 8 million tons, up from 7 million tons year-over-year [5]. - The estimated 'INTEGRATED GAS - Realised liquids price' is $55.89 per barrel, compared to $63.45 in the same quarter last year [6]. - The consensus for 'CHEMICALS & PRODUCTS - Global indicative refining margin' is $13.56 per barrel, significantly up from $5.54 in the same quarter last year [6]. - 'CHEMICALS & PRODUCTS - Refinery utilisation' is expected to be 93.0%, a notable increase from 76.0% year-over-year [7]. - 'CHEMICALS & PRODUCTS - Chemicals sales volumes' are projected at 2469 thousand tons, down from 2926 thousand tons in the same quarter last year [7]. - The estimated 'UPSTREAM - Realised liquids price' is $60.34 per barrel, compared to $70.69 in the same quarter last year [9]. Stock Performance - Over the past month, Shell shares have returned +0.9%, while the Zacks S&P 500 composite has changed by +1.8% [11]. - Shell currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [11].

Core Insights - ResMed (RMD) is expected to report quarterly earnings of $2.68 per share, reflecting a 10.3% increase year-over-year, with revenues projected at $1.39 billion, an 8.3% increase from the previous year [1] Earnings Projections - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [2] Analyst Forecasts - Analysts project 'Global revenue- Total Sleep and Breathing Health' to be $1.20 billion, indicating a 6.3% year-over-year increase [4] - 'Global revenue- Total Devices' is expected to reach $712.11 million, reflecting a 6.4% increase from the prior year [4] - 'Global revenue- Total Masks and other' is estimated at $500.27 million, suggesting a 9.6% year-over-year change [4] Regional Revenue Estimates - The consensus for 'U.S., Canada, and Latin America- Devices' is $439.35 million, indicating a 6% increase year-over-year [5] - 'U.S., Canada, and Latin America- Masks and other' is projected to reach $367.97 million, reflecting a 10% increase from the previous year [5] - 'Combined Europe, Asia, and other markets- Total' is expected to be $405.06 million, indicating a 7.6% year-over-year change [5] Additional Market Insights - 'Combined Europe, Asia, and other markets- Devices' is estimated at $272.76 million, suggesting a 7.1% increase year-over-year [6] - 'Combined Europe, Asia, and other markets- Masks and other' is projected to be $132.30 million, reflecting an 8.6% increase from the prior year [6] - The estimated 'U.S., Canada, and Latin America- Total' is $807.32 million, indicating a 7.8% increase year-over-year [7] Stock Performance - ResMed shares have returned +5.2% over the past month, outperforming the Zacks S&P 500 composite's +0.4% change, with a Zacks Rank 2 (Buy) indicating expected outperformance in the near future [7]